We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+10.97%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$11.8B
AUM Growth
+$11.7B
Cap. Flow
+$973M
Cap. Flow %
8.28%
Top 10 Hldgs %
24.41%
Holding
296
New
40
Increased
100
Reduced
97
Closed
30

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$166M
2
AMGN icon
Amgen
AMGN
+$123M
3
ADSK icon
Autodesk
ADSK
+$114M
4
UNH icon
UnitedHealth
UNH
+$103M
5
MRK icon
Merck
MRK
+$102M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$78.6M
2
AMD icon
Advanced Micro Devices
AMD
+$74.2M
3
TMO icon
Thermo Fisher Scientific
TMO
+$65.6M
4
UNP icon
Union Pacific
UNP
+$36.4M
5
ILMN icon
Illumina
ILMN
+$26.4M

Sector Composition

Rank Sector Weight
1 Technology 24.57%
2 Financials 22.21%
3 Healthcare 21.91%
4 Communication Services 9.53%
5 Industrials 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPLK
126
DELISTED
Splunk Inc
SPLK
$27.8M 0.24%
229,669
-52,416
-19% -$5.81M
PRA
127
DELISTED
ProAssurance
PRA
$27M 0.23%
575,000
+50,000
+10% +$2.2M
JAZZ icon
128
Jazz Pharmaceuticals
JAZZ
$16.1B
$26.8M 0.23%
159,500
+59,500
+60% +$10.2M
KEYS icon
129
Keysight
KEYS
$52.2B
$26.5M 0.23%
400,244
-62,926
-14% -$3.9M
BIIB icon
130
Biogen
BIIB
$30.4B
$26.5M 0.23%
75,000
– –
EVBG
131
DELISTED
Everbridge, Inc. Common Stock
EVBG
$26.5M 0.23%
459,080
-52,302
-10% -$2.82M
REGN icon
132
Regeneron Pharmaceuticals
REGN
$72.9B
$26.3M 0.22%
65,000
+25,000
+63% +$9.51M
MIME
133
DELISTED
Mimecast Limited
MIME
$26.1M 0.22%
622,384
-63,714
-9% -$2.59M
LITE icon
134
Lumentum
LITE
$50.7B
$26M 0.22%
433,362
+15,986
+4% +$956K
NEWR
135
DELISTED
New Relic, Inc.
NEWR
$25.9M 0.22%
275,249
+28,175
+11% +$2.92M
FCX icon
136
Freeport-McMoran
FCX
$88.6B
$25.7M 0.22%
1,848,350
-230,285
-11% -$3.48M
EA icon
137
Electronic Arts
EA
$52.4B
$24.8M 0.21%
205,912
-173,568
-46% -$22.4M
NTNX icon
138
Nutanix
NTNX
$16B
$24.8M 0.21%
579,833
-51,050
-8% -$2.7M
TPL icon
139
Texas Pacific Land
TPL
$26.9B
$24.7M 0.21%
+257,832
New +$22.9M
RLI icon
140
RLI Corp
RLI
$5.97B
$24.2M 0.21%
617,000
+3,200
+0.5% +$120K
RNG icon
141
RingCentral
RNG
$4.77B
$23.9M 0.2%
257,195
-69,709
-21% -$6.02M
SIEN
142
DELISTED
Sientra, Inc.
SIEN
$23.9M 0.2%
100,000
+43,403
+77% +$9.53M
OLED icon
143
Universal Display
OLED
$3.85B
$23.5M 0.2%
199,140
-35,627
-15% -$3.92M
FIVN icon
144
FIVE9
FIVN
$2.08B
$23.4M 0.2%
535,129
-203,499
-28% -$8.39M
AMRN
145
Amarin Corp
AMRN
$293M
$22.6M 0.19%
+69,589
New +$5.26M
ZGNX
146
DELISTED
Zogenix, Inc.
ZGNX
$22.4M 0.19%
451,302
-97,017
-18% -$4.94M
ALNY icon
147
Alnylam Pharmaceuticals
ALNY
$38.5B
$21.4M 0.18%
244,287
+29,287
+14% +$2.95M
ACRS icon
148
Aclaris Therapeutics
ACRS
$744M
$21M 0.18%
1,443,920
-206,795
-13% -$3.54M
RIG icon
149
Transocean
RIG
$5.52B
$20.9M 0.18%
+1,500,000
New +$18.6M
AFL icon
150
Aflac
AFL
$65.9B
$20M 0.17%
425,000
-15,000
-3% -$686K
4 5
6
7 8

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q3 2018 Portfolio in Review

As of Q3 2018, Polar Capital held 296 positions worth $11.8B, up 70,685% from $16.6M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Polar Capital deployed $973M of net new capital in Q3 2018, opening 40 new positions and adding to 100 existing holdings. Its largest new stake was Johnson & Johnson: 1,250,000 shares worth $173M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $78.6M trimmed.

  • Polar Capital's largest Q3 2018 buy was Johnson & Johnson: 1,250,000 shares worth $173M.
  • Polar Capital added most to UnitedHealth in Q3 2018, an estimated $103M increase.
  • Polar Capital's biggest Q3 2018 reduction was Meta Platforms (Facebook), cutting an estimated $78.6M.
  • Polar Capital fully exited Amdocs in Q3 2018, selling an estimated $46.6K.
  • Polar Capital's ten largest holdings make up 24% of its $11.8B portfolio in Q3 2018.
  • Polar Capital opened 40 new positions and closed 30 in Q3 2018.
  • Polar Capital's portfolio value rose 70,685% quarter-over-quarter to $11.8B.

Based on Polar Capital's 13F filing for Q3 2018, filed 14 Nov 2018.